Genprex's Unattributed - II Round

Genprex raised a round of funding on December 30, 2013.

Genprex is a privately held, clinical-stage biopharmaceutical company developing nanovesicle therapies that control universal cancer pathways to unlock the unrealized potential of a variety of targete…

Articles about Genprex's Unattributed - II Round: